Dorling Janet's most recent trade in Cymabay Therapeutics Inc was a trade of 67,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on March 22, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cymabay Therapeutics Inc | Janet Dorling | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 67,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Janet Dorling | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 55,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Janet Dorling | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 25,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Janet Dorling | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Mar 2024 | 14,010 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Janet Dorling | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2024 | 6,000 | 55,000 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Janet Dorling | Director | Sale of securities on an exchange or to another person at price $ 31.97 per share. | 12 Feb 2024 | 6,000 | 0 (0%) | 0% | 32.0 | 191,849 | Common Stock |
| Cymabay Therapeutics Inc | Dorling Janet | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.63 per share. | 12 Feb 2024 | 6,000 | 6,000 (0%) | 0% | 4.6 | 27,780 | Common Stock |
| Cymabay Therapeutics Inc | Dorling Janet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 14,010 | 14,010 | - | - | Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Dorling Janet | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jan 2024 | 6,000 | 61,000 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Dorling Janet | Director | Sale of securities on an exchange or to another person at price $ 23.86 per share. | 10 Jan 2024 | 6,000 | 0 (0%) | 0% | 23.9 | 143,144 | Common Stock |
| Cymabay Therapeutics Inc | Janet Dorling | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.63 per share. | 10 Jan 2024 | 6,000 | 6,000 (0%) | 0% | 4.6 | 27,780 | Common Stock |
| Cymabay Therapeutics Inc | Dorling Janet | Director | Sale of securities on an exchange or to another person at price $ 20.07 per share. | 11 Dec 2023 | 6,000 | 0 (0%) | 0% | 20.1 | 120,422 | Common Stock |
| Cymabay Therapeutics Inc | Janet Dorling | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2023 | 6,000 | 67,000 | - | - | Employee Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Janet Dorling | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.63 per share. | 11 Dec 2023 | 6,000 | 6,000 (0%) | 0% | 4.6 | 27,780 | Common Stock |
| Cymabay Therapeutics Inc | Janet Dorling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Janet Dorling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 67,000 | 67,000 | - | - | Stock Option (right to buy) | |
| Cymabay Therapeutics Inc | Janet Dorling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2021 | 80,000 | 80,000 | - | - | Stock Option (right to buy) |